HHS Regs Roundup: Health Bureaucracy on Autopilot
Published Date: 8/14/2026
Proposed Rule
Summary
The Regulatory Flexibility Act of 1980 and Executive Order 12866 require the issuance of an inventory of rulemaking actions under development throughout the Department, offering for public review summarized information about forthcoming regulatory actions.
Analyzed Economic Effects
7 provisions identified: 5 benefits, 1 costs, 1 mixed.
Marketplace Subsidy Verification Change
Because of the Working Families Tax Cut law (Public Law 119-21), beginning with plan year 2028 individuals will not receive advance premium tax credit (APTC) payments until they have successfully verified eligibility through an Exchange documentation process. Exchanges must provide a pre-enrollment verification process no later than August 1, 2027, and Open Enrollment for plan year 2028 begins November 1, 2027.
Web and App Accessibility Deadlines
HHS finalized a rule (May 9, 2024) requiring recipients with 15 or more employees to make their websites and mobile apps accessible to people with disabilities, with a compliance date of May 11, 2026. The Department issued an interim final rule extending the deadlines and says it will consider a new proposed rule to reconsider whether some requirements can be made less burdensome.
Opioid Treatment Access Expanded
SAMHSA will revise 42 CFR part 8 to make permanent some COVID-era flexibilities for Opioid Treatment Programs, update rules for unsupervised methadone doses, allow initiation of buprenorphine by telemedicine, and update admission criteria to expand timely access to care. SAMHSA estimates these changes will impact roughly 1,900 opioid treatment programs and state opioid treatment authorities.
No Surprises Act IDR Rules Finalized
CMS finalized rules implementing parts of the No Surprises Act’s Federal independent dispute resolution (IDR) process. The final rule requires plans and issuers to include specified information with initial payment or denial notices, to use claim adjustment reason codes (CARCs) and remittance advice remark codes (RARCs) for certain remittance communications, and it amends rules on the open negotiation period, initiation and eligibility review for Federal IDR, and payment/collection of administrative and certified IDR entity fees.
Reduce Provider Administrative Burdens
CMS proposes a rule titled 'Cutting Administrative Requirements for Excellence in Patient Care' to modernize Conditions of Participation and Conditions for Coverage, eliminate obsolete or excessively burdensome regulations, and increase flexibility for Medicare- and Medicaid-participating providers. The NPRM target listed is August 2026.
Patient Medication Information Required
FDA will require a new form of patient labeling called Patient Medication Information for human prescription drug products and certain outpatient blood products; manufacturers must submit this information to FDA for approval. The rulemaking is scheduled with a final rule target of December 2026.
Front-of-Package Nutrition Labels
FDA proposes requiring front-of-package nutrition labeling on packaged foods to display certain nutrition information to help consumers make quicker, informed dietary choices; the rule would also amend certain nutrient content claim regulations. The rulemaking lists a final rule target of December 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16414, Adoption and Foster Care Analysis and Reporting System
This document withdraws a proposed rule that was published in the Federal Register on January 11, 2008. The proposed rule would have amended the Adoption and Foster Care Analysis and Reporting System (AFCARS) regulations at 45 CFR 1355.40 and the appendices to Part 1355 to modify the requirements for States to collect and report data to ACF on children in out-of-home care and in subsidized adoption or guardianship arrangements with the State. This document also withdraws the provision of the 2008 proposed rule that implemented the AFCARS penalty requirements of the Adoption Promotion Act of 2003 (Pub. L. 108-145).
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-12069, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
Previous / Next Documents
Previous: 2026-16596, Unified Agenda of Federal Regulatory and Deregulatory Actions
The Secretary of Education publishes an l agenda of Federal regulatory and deregulatory actions. The agenda is issued under the authority of section 4(b) of Executive Order 12866, Regulatory Planning and Review. The purpose of the agenda is to encourage more effective public participation in the regulatory process by providing the public with early information about the regulatory actions we plan to take.
Next: 2026-16598, Regulatory Agenda
This notice provides the Department of the Interior's (Department) Unified Agenda of Federal Regulatory and Deregulatory Actions (Agenda). The Regulatory Flexibility Act and Executive Order 12866 require publication of the Agenda.